THUMPD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.37254660362396E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.55773180413144E-12 |
Normal-vs-Stage2 |
7.76700000000297E-05 |
Normal-vs-Stage3 |
1.53200000019282E-07 |
Normal-vs-Stage4 |
2.031400E-04 |
Stage1-vs-Stage2 |
6.081000E-01 |
Stage1-vs-Stage3 |
3.937000E-01 |
Stage1-vs-Stage4 |
1.987810E-02 |
Stage2-vs-Stage3 |
3.383800E-01 |
Stage2-vs-Stage4 |
7.380500E-02 |
Stage3-vs-Stage4 |
2.108600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.93629556832775E-11 |
Normal-vs-AfricanAmerican |
3.11750000037136E-07 |
Normal-vs-Asian |
2.91489998804906E-09 |
Caucasian-vs-AfricanAmerican |
2.459900E-02 |
Caucasian-vs-Asian |
2.808400E-02 |
AfricanAmerican-vs-Asian |
2.578200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.2422000901563E-10 |
Normal-vs-Female |
2.07334149848748E-12 |
Male-vs-Female |
1.542240E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.365600E-02 |
Normal-vs-Age(41-60Yrs) |
5.6799009939823E-11 |
Normal-vs-Age(61-80Yrs) |
5.0785042837731E-11 |
Normal-vs-Age(81-100Yrs) |
1.182470E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.800200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.481800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.581800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.912600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.838000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.969400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.88019999999689E-05 |
Normal-vs-Grade 2 |
1.7457146839206E-12 |
Normal-vs-Grade 3 |
4.72100003534592E-09 |
Normal-vs-Grade 4 |
5.436800E-03 |
Grade 1-vs-Grade 2 |
3.223500E-02 |
Grade 1-vs-Grade 3 |
6.187600E-04 |
Grade 1-vs-Grade 4 |
3.76790000000682E-05 |
Grade 2-vs-Grade 3 |
2.671800E-02 |
Grade 2-vs-Grade 4 |
6.434300E-04 |
Grade 3-vs-Grade 4 |
8.576200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62458935193399E-12 |
Normal-vs-ccB subtype |
1.921420E-03 |
ccA subtype-vs-ccB subtype |
1.25239999482218E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.8016033937206E-11 |
Normal-vs-N1 |
3.007000E-01 |
N0-vs-N1 |
1.236010E-01 |
|
|